GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (OTCPK:AZNCF) » Definitions » Shiller PE Ratio

AZNCF (AstraZeneca) Shiller PE Ratio : 49.93 (As of Apr. 14, 2025)


View and export this data going back to 2009. Start your Free Trial

What is AstraZeneca Shiller PE Ratio?

As of today (2025-04-14), AstraZeneca's current share price is $131.31. AstraZeneca's E10 for the quarter that ended in Dec. 2024 was $2.63. AstraZeneca's Shiller PE Ratio for today is 49.93.

The historical rank and industry rank for AstraZeneca's Shiller PE Ratio or its related term are showing as below:

AZNCF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.26   Med: 35.92   Max: 75.22
Current: 46.73

During the past years, AstraZeneca's highest Shiller PE Ratio was 75.22. The lowest was 14.26. And the median was 35.92.

AZNCF's Shiller PE Ratio is ranked worse than
82.63% of 524 companies
in the Drug Manufacturers industry
Industry Median: 23.615 vs AZNCF: 46.73

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AstraZeneca's adjusted earnings per share data for the three months ended in Dec. 2024 was $0.960. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $2.63 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AstraZeneca Shiller PE Ratio Historical Data

The historical data trend for AstraZeneca's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Shiller PE Ratio Chart

AstraZeneca Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.15 52.72 71.22 59.70 49.43

AstraZeneca Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.70 57.14 63.81 58.05 49.43

Competitive Comparison of AstraZeneca's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.


;
;

AstraZeneca Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=131.31/2.63
=49.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.96/135.1000*135.1000
=0.960

Current CPI (Dec. 2024) = 135.1000.

AstraZeneca Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 0.440 99.600 0.597
201506 0.550 100.100 0.742
201509 0.600 100.200 0.809
201512 0.630 100.400 0.848
201603 0.510 100.400 0.686
201606 -0.002 101.000 -0.003
201609 0.800 101.500 1.065
201612 1.450 102.200 1.917
201703 0.420 102.700 0.553
201706 0.380 103.500 0.496
201709 0.540 104.300 0.699
201712 1.030 105.000 1.325
201803 0.270 105.100 0.347
201806 0.270 105.900 0.344
201809 0.340 106.600 0.431
201812 0.820 107.100 1.034
201903 0.470 107.000 0.593
201906 0.090 107.900 0.113
201909 0.230 108.400 0.287
201912 0.240 108.500 0.299
202003 0.590 108.600 0.734
202006 0.580 108.800 0.720
202009 0.490 109.200 0.606
202012 0.780 109.400 0.963
202103 1.180 109.700 1.453
202106 0.420 111.400 0.509
202109 -1.100 112.400 -1.322
202112 -0.220 114.700 -0.259
202203 0.250 116.500 0.290
202206 0.230 120.500 0.258
202209 1.050 122.300 1.160
202212 0.580 125.300 0.625
202303 1.160 126.800 1.236
202306 1.170 129.400 1.222
202309 0.880 130.100 0.914
202312 0.620 130.500 0.642
202403 1.400 131.600 1.437
202406 1.240 133.000 1.260
202409 0.910 133.500 0.921
202412 0.960 135.100 0.960

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AstraZeneca  (OTCPK:AZNCF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AstraZeneca Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.